Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Grant Industries, Inc.
483
•Grant Industries, Inc.•June 16, 2025

Grant Industries, Inc. – FDA 483, Jun 16, 2025

Record Details

During an inspection conducted from June 11 to June 16, 2025, the U.S. Food and Drug Administration (FDA) issued a Form 483 to an unnamed firm, citing significant deviations from current Good Manufacturing Practices (cGMP). The observations highlight critical issues across quality control, production, laboratory, and training systems. Key violations included the quality control unit's failure to adequately manage out-of-specification material, specifically releasing a reworked Zinc Oxide batch after multiple retests without stability assessment, and implementing unjustified changes to product specifications. The firm also lacked adequate production and process controls, evidenced by the absence of protocol-driven process validation studies for drug products and unvalidated critical laboratory equipment. Furthermore, the inspection revealed a deficient stability program, lacking forced degradation studies for analytical methods and inadequate evaluation of impurity detection during method validations. Computer systems for GMP operations were found to have insufficient controls, including a lack of second-person data review, an enabled data deletion function with administrative access, and an unvalidated inventory management system. Other issues included incomplete laboratory records, with unqualified secondary standards and absent documentation for solution preparations. Critical component testing was deficient, as incoming Glycerin USP was not tested for diethylene glycol and ethylene glycol. Finally, an employee performing critical FT-IR identification testing lacked documented training for the procedure. The firm is required to address these serious deficiencies with robust corrective actions to ensure product quality and regulatory compliance.

Company
Grant Industries, Inc.
Inspection date
June 16, 2025
Product type
drugs
Office
New Jersey District Office
People
  • Suchan Kim
  • Syeda N. Mahazabin (Drug Investigator)
View Company Profile

ID · 41ef8fcc-2571-42b4-8c0c-c7112ad4d960

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Grant Industries, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.